We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

October 8, 2010

CELGENE CORPORATION v. NATCO PHARMA LIMITED

Track this case

Case Number:

2:10-cv-05197

Court:

New Jersey

Nature of Suit:

Patent

Judge:

Susan D. Wigenton

Firms

Companies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. December 22, 2015

    Celgene Allows Earlier Cancer Drug Generic In Patent Deal

    Celgene Corp. has agreed to allow an India-based drugmaker to sell a generic version of its blood cancer treatment in the U.S. more than a year before the last-to-expire patent covering the drug runs out, as part of a settlement the companies reached Tuesday.

1 other articles on this case. View all »

Parties

To view the parties, register now.